Universal Newborn Hearing Screening: The Evolution of a Public Health Revolution

2014 ◽  
Vol 1 (1) ◽  
pp. 1
Author(s):  
Christine Yoshinaga-Itano
1997 ◽  
Vol 6 (1) ◽  
pp. 11-16
Author(s):  
Terrey Oliver Penn ◽  
Susan E. Abbott

2021 ◽  
Vol 5 (1) ◽  
pp. e000976
Author(s):  
Ayanda Gina ◽  
Nadja F Bednarczuk ◽  
Asitha Jayawardena ◽  
Peter Rea ◽  
Qadeer Arshad ◽  
...  

Hearing screening for newborn babies is an established protocol in many high-income countries. Implementing such screening has yielded significant socioeconomic advantages at both an individual and societal level. This has yet to permeate low/middle-income countries (LMIC). Here, we illustrate how newborn hearing screening needs to be contextually adapted for effective utilisation and implementation in an LMIC. Specifically, this advocates the use of auditory brainstem testing as the first-line approach. We propose that such adaptation serves to maximise clinical efficacy and community participation at a reduced cost.


Author(s):  
Philippa Horn ◽  
Carlie Driscoll ◽  
Jane Fitzgibbons ◽  
Rachael Beswick

Purpose The current Joint Committee on Infant Hearing guidelines recommend that infants with syndromes or craniofacial abnormalities (CFAs) who pass the universal newborn hearing screening (UNHS) undergo audiological assessment by 9 months of age. However, emerging research suggests that children with these risk factors are at increased risk of early hearing loss despite passing UNHS. To establish whether earlier diagnostic audiological assessment is warranted for all infants with a syndrome or CFA, regardless of screening outcome, this study compared audiological outcomes of those who passed UNHS and those who referred. Method A retrospective analysis was performed on infants with a syndrome or CFA born between July 1, 2012, and June 30, 2017 who participated in Queensland, Australia's state-wide UNHS program. Results Permanent childhood hearing loss (PCHL) yield was higher among infants who referred on newborn hearing screening (51.20%) than in those who passed. Nonetheless, 27.47% of infants who passed were subsequently diagnosed with hearing loss (4.45% PCHL, 23.02% transient conductive), but PCHL was generally milder in this cohort. After microtia/atresia, the most common PCHL etiologies were Trisomy 21, other syndromes, and cleft palate. Of the other syndromes, Pierre Robin sequence featured prominently among infants who passed the hearing screen and were subsequently diagnosed with PCHL, whereas there was a broader mix of other syndromes that caused PCHL in infants who referred on screening. Conclusion Children identified with a syndrome or CFA benefit from early diagnostic audiological assessment, regardless of their newborn hearing screening outcome.


2015 ◽  
Vol 82 (8) ◽  
pp. 688-693 ◽  
Author(s):  
Shuchita Gupta ◽  
Sandhya Sah ◽  
Tapas Som ◽  
Manju Saksena ◽  
Chander Prakash Yadav ◽  
...  

2004 ◽  
Vol 5 (sup1) ◽  
pp. 206-208
Author(s):  
Raymond YS Ngo ◽  
Henry KK Tan ◽  
A Balakrishnan ◽  
Derek Lazaroo ◽  
Seok Bee Lim ◽  
...  

2007 ◽  
Vol 71 (2) ◽  
pp. 217-230 ◽  
Author(s):  
Lia M. Ferro ◽  
Gail Tanner ◽  
Susan F. Erler ◽  
Kristine Erickson ◽  
Sumitrajit Dhar

Sign in / Sign up

Export Citation Format

Share Document